Recce Pharmaceuticals (ASX:RCE) gains ethics approval to expand phase I/II trial of R327

alt="James Graham CEO of Recce Pharmaceuticals"

Recce Pharmaceuticals (ASX:RCE) gains ethics approval to expand phase I/II trial of R327